Hepatocellular Carcinoma Recurrence and Anesthesia
Overview
The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: June 2019
Interventions
- Other: Volatile anesthetics
- Other: Intravenous anesthetics
Arms, Groups and Cohorts
- Volatile
- The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using volatile anesthetics as maintenance agents.
- Intravenous
- The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using intravenous anesthetics as maintenance agents.
Clinical Trial Outcome Measures
Primary Measures
- Recurrence of HCC
- Time Frame: Postoperative 2 year
Participating in This Clinical Trial
Inclusion Criteria
- Patients undergoing surgery due to the HCC. Exclusion Criteria:
- Patients undergoing re-operation due to the HCC. – Patients presenting distant metastasis. – Patients undergoing liver transplantation surgery.
Gender Eligibility: All
Minimum Age: 20 Years
Maximum Age: 100 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Seoul National University Bundang Hospital
- Provider of Information About this Clinical Study
- Principal Investigator: Hyo-Seok Na, Dr – Seoul National University Bundang Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.